Tara Dall, MD, FNLA

home / authors / tara-dall-md-fnla

Articles

Untapped Potentials - Exploring Overlooked Therapies for Type 2 Diabetes

Untapped Potentials - Exploring Overlooked Therapies for Type 2 Diabetes

Dhiren Patel, PharmD, CECES, BC-ADM;Robert Busch, MD;Tara Dall, MD, FNLA
October 9th 2023

In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.

Read More

Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes

Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes

Dhiren Patel, PharmD, CECES, BC-ADM;Robert Busch, MD;Tara Dall, MD, FNLA
September 29th 2023

In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Published: November 19th 2024 | Updated: November 21st 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Widespread "Yellow Bumps"
Published: October 9th 2014 | Updated: November 21st 2024
Widespread "Yellow Bumps"
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
Published: November 18th 2024 | Updated: November 21st 2024
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Published: November 16th 2024 | Updated: November 21st 2024
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
© 2024 MJH Life Sciences

All rights reserved.